BioCryst在Acaai上发布新数据,突显Hae对儿童患者和照顾者的负担以及使用Orladeyo®(Berotralstat)治疗一年后儿童攻击次数的持续减少

美股速递
Yesterday

BioCryst在Acaai上发布新数据,突显Hae对儿童患者和照顾者的负担以及使用Orladeyo®(Berotralstat)治疗一年后儿童攻击次数的持续减少

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10